National Bank of Canada
DGX icon

National Bank of Canada’s Quest Diagnostics DGX Stock Holding History

National Bank of Canada’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.6M Sell
48,962
-50,830
-51% -$9.88M 0.01% 702
2025
Q4 		$17.3M Buy
99,792
+43,270
+77% +$7.88M 0.02% 563
2025
Q3 		$10.8M Sell
56,522
-45,696
-45% -$8.11M 0.01% 675
2025
Q2 		$18.4M Buy
102,218
+27,330
+36% +$4.75M 0.02% 579
2025
Q1 		$12.7M Buy
74,888
+22,626
+43% +$3.72M 0.01% 646
2024
Q4 		$7.88M Sell
52,262
-29,622
-36% -$4.61M 0.01% 848
2024
Q3 		$12.7M Buy
81,884
+50,780
+163% +$7.58M 0.01% 608
2024
Q2 		$4.26M Buy
31,104
+6,025
+24% +$825K 0.01% 777
2024
Q1 		$3.47M Sell
25,079
-77,179
-75% -$10M 0.01% 898
2023
Q4 		$14.4M Buy
102,258
+70,922
+226% +$9.32M 0.02% 489
2023
Q3 		$3.79M Buy
31,336
+6,114
+24% +$815K 0.01% 883
2023
Q2 		$3.51M Buy
25,222
+10,807
+75% +$1.49M 0.01% 819
2023
Q1 		$2.05M Buy
14,415
+4,033
+39% +$577K 0.01% 848
2022
Q4 		$1.62M Buy
10,382
+190
+2% +$27.3K ﹤0.01% 929
2022
Q3 		$1.28M Sell
10,192
-2,361
-19% -$311K 0.01% 907
2022
Q2 		$1.71M Buy
12,553
+32
+0.3% +$4.36K 0.01% 837
2022
Q1 		$1.73M Buy
12,521
+654
+6% +$91.2K 0.01% 920
2021
Q4 		$1.89M Buy
+11,867
New +$1.81M 0.01% 841

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

National Bank of Canada's DGX Position: Q1 2026 in Review

National Bank of Canada reduced its Quest Diagnostics (DGX) stake by 51% in Q1 2026, selling an estimated $9.88M and leaving 48,962 shares worth $9.6M. The position accounts for 0.01% of the portfolio, ranked #702.

National Bank of Canada first reported a position in DGX in Q4 2021 and has held it in 18 quarters since. The position peaked at $18.4M in Q2 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • National Bank of Canada held 48,962 shares of Quest Diagnostics worth $9.6M as of Q1 2026.
  • National Bank of Canada sold 50,830 Quest Diagnostics shares in Q1 2026, an estimated $9.88M.
  • Quest Diagnostics made up 0.01% of National Bank of Canada's portfolio in Q1 2026, its #702 holding.
  • National Bank of Canada first reported a position in Quest Diagnostics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Quest Diagnostics position peaked at $18.4M in Q2 2025.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.